ArticleFrontiers in endocrinology2018

Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action.

Daniel Aizen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.